Principal Financial Group
IART icon

Principal Financial Group’s Integra LifeSciences IART Stock Holding History

Principal Financial Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.81M Sell
323,383
-2,260
-0.7% -$31.6K ﹤0.01% 1622
2026
Q1 		$3.07M Sell
325,643
-112,303
-26% -$1.23M ﹤0.01% 1764
2025
Q4 		$5.44M Buy
437,946
+35,734
+9% +$475K ﹤0.01% 1587
2025
Q3 		$5.76M Buy
402,212
+25,995
+7% +$356K ﹤0.01% 1535
2025
Q2 		$4.62M Sell
376,217
-57,707
-13% -$838K ﹤0.01% 1605
2025
Q1 		$9.54M Buy
433,924
+10,492
+2% +$247K 0.01% 1288
2024
Q4 		$9.6M Buy
423,432
+22,000
+5% +$480K 0.01% 1314
2024
Q3 		$7.29M Buy
401,432
+63,266
+19% +$1.47M ﹤0.01% 1427
2024
Q2 		$9.85M Buy
338,166
+82,056
+32% +$2.43M 0.01% 1271
2024
Q1 		$9.08M Buy
256,110
+6,238
+2% +$249K 0.01% 1359
2023
Q4 		$10.9M Sell
249,872
-11,429
-4% -$450K 0.01% 1244
2023
Q3 		$9.98M Sell
261,301
-6,277
-2% -$264K 0.01% 1231
2023
Q2 		$11M Sell
267,578
-20,006
-7% -$963K 0.01% 1200
2023
Q1 		$16.5M Buy
287,584
+2,704
+0.9% +$152K 0.01% 962
2022
Q4 		$16M Buy
284,880
+1,710
+0.6% +$87K 0.01% 966
2022
Q3 		$12M Buy
283,170
+1,614
+0.6% +$82.7K 0.01% 1079
2022
Q2 		$15.2M Buy
281,556
+33,918
+14% +$2.04M 0.01% 1022
2022
Q1 		$15.9M Buy
247,638
+157
+0.1% +$10.3K 0.01% 1074
2021
Q4 		$16.6M Sell
247,481
-3,906
-2% -$264K 0.01% 1080
2021
Q3 		$17.2M Buy
251,387
+4,267
+2% +$301K 0.01% 1059
2021
Q2 		$16.9M Buy
247,120
+3,414
+1% +$241K 0.01% 1114
2021
Q1 		$16.8M Buy
243,706
+34,033
+16% +$2.31M 0.01% 1061
2020
Q4 		$13.6M Sell
209,673
-303
-0.1% -$16.3K 0.01% 1048
2020
Q3 		$9.92M Sell
209,976
-6,366
-3% -$303K 0.01% 1081
2020
Q2 		$10.2M Sell
216,342
-1,786
-0.8% -$87.8K 0.01% 1046
2020
Q1 		$9.74M Sell
218,128
-90,660
-29% -$4.76M 0.01% 921
2019
Q4 		$18M Buy
308,788
+551
+0.2% +$32.8K 0.02% 883
2019
Q3 		$18.5M Sell
308,237
-5,168
-2% -$308K 0.02% 825
2019
Q2 		$17.5M Sell
313,405
-1,891
-0.6% -$97.4K 0.02% 862
2019
Q1 		$17.6M Buy
315,296
+3,105
+1% +$158K 0.02% 871
2018
Q4 		$14.1M Sell
312,191
-4,964
-2% -$272K 0.02% 939
2018
Q3 		$20.9M Buy
317,155
+1,696
+0.5% +$105K 0.02% 831
2018
Q2 		$20.3M Sell
315,459
-179,276
-36% -$11.1M 0.02% 815
2018
Q1 		$27.4M Buy
494,735
+10,388
+2% +$544K 0.03% 608
2017
Q4 		$23.2M Sell
484,347
-4,874
-1% -$239K 0.02% 720
2017
Q3 		$24.7M Buy
489,221
+14,833
+3% +$762K 0.02% 660
2017
Q2 		$25.9M Buy
474,388
+5,708
+1% +$273K 0.03% 639
2017
Q1 		$19.7M Buy
468,680
+16,000
+4% +$684K 0.02% 720
2016
Q4 		$19.4M Buy
452,680
+3,698
+0.8% +$150K 0.02% 711
2016
Q3 		$18.5M Buy
448,982
+31,212
+7% +$1.31M 0.02% 702
2016
Q2 		$16.7M Buy
417,770
+10,628
+3% +$382K 0.02% 732
2016
Q1 		$13.7M Buy
407,142
+13,616
+3% +$424K 0.02% 791
2015
Q4 		$13.3M Buy
393,526
+25,808
+7% +$807K 0.02% 769
2015
Q3 		$10.9M Sell
367,718
-20,975
-5% -$656K 0.02% 860
2015
Q2 		$10.7M Sell
388,693
-7,868
-2% -$210K 0.02% 946
2015
Q1 		$9.99M Buy
396,561
+9,585
+2% +$227K 0.01% 972
2014
Q4 		$8.58M Buy
386,976
+480
+0.1% +$9.73K 0.01% 1072
2014
Q3 		$7.84M Buy
386,496
+15,396
+4% +$306K 0.01% 1055
2014
Q2 		$7.14M Sell
371,100
-2,259
-0.6% -$42.1K 0.01% 1164
2014
Q1 		$7.02M Buy
373,359
+25,581
+7% +$494K 0.01% 1147
2013
Q4 		$6.78M Buy
347,778
+51,718
+17% +$949K 0.01% 1148
2013
Q3 		$4.87M Buy
296,060
+10,978
+4% +$176K 0.01% 1291
2013
Q2 		$4.27M Buy
+285,082
New +$4.18M 0.01% 1302

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Principal Financial Group's IART Position: Q2 2026 in Review

Principal Financial Group reduced its Integra LifeSciences (IART) stake by 0.69% in Q2 2026, selling an estimated $31.6K and leaving 323,383 shares worth $5.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Principal Financial Group first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.4M in Q1 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Principal Financial Group held 323,383 shares of Integra LifeSciences worth $5.81M as of Q2 2026.
  • Principal Financial Group sold 2,260 Integra LifeSciences shares in Q2 2026, an estimated $31.6K.
  • Integra LifeSciences made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1622 holding.
  • Principal Financial Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
  • Principal Financial Group's Integra LifeSciences position peaked at $27.4M in Q1 2018.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.